We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Febuxostat (FBX)

Australian Public Assessment Report

AusPAR

AusPAR: Febuxostat (FBX) [PDF, 823.72 KB]

AusPAR: Febuxostat (FBX) [Word, 542.16 KB]

Attachment: Product Information: Febuxostat (FBX) [PDF, 300.45 KB]

Attachment: Product Information: Febuxostat (FBX) [Word, 74.7 KB]

Attachment: Extract from the Clinical Evaluation Report: Febuxostat (FBX) [PDF, 854.76 KB]

Attachment: Extract from the Clinical Evaluation Report: Febuxostat (FBX) [Word, 472.06 KB]

Device/Product Name

Adenuric

Active ingredients

Febuxostat (FBX)

AusPAR Date

8 January 2015

Published

25 February 2015

Submission Number

PM-2012-03425-1-3

Submission Type

New chemical entity

Decision

Approved